These innovative companies are working on new methods to make chemotherapy safer, and more tolerable, for cancer patients in America. » Read More
Mylan has raised prices of the anti-allergy device more than 500 percent in recent years. » Read More
Eli Lilly reported third-quarter revenue below Wall Street estimates, driven by lower demand for its products outside the United States. » Read More
Merck reported a 19.6 percent rise in net profit, driven primarily by higher demand for its new cancer drug Keytruda. » Read More
Get the best of CNBC in your inbox
Dan Mangan is a reporter covering health care for CNBC.com.
Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.
Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.